Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene (SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis

Clinical Genetics

Volumn 71, Issue 5, 2007, Pages 451-457

  Tzetis, Maria ^a,e   Kaliakatsos, M ^a   Fotoulaki, B ^b   Papatheodorou, A ^a   Doudounakis, S ^c   Tsezou, A ^d   Makrythanasis, P ^a   Kanavakis, E ^a   Nousia arvanitakis, S ^b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d UNIVERSITY OF THESSALY   (Greece)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

CFTR; Chronic pancreatitis; PRSS1; Recurrent pancreatitis; SPINK1

Indexed keywords

APROTININ; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRYPSINOGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; GREECE; HAPLOTYPE; HETEROZYGOSITY; HIGH RISK PATIENT; HOMOZYGOTE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECURRENT DISEASE;

ADOLESCENT; ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATITIS, CHRONIC; TRYPSINOGEN;

EID: 34248327329     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2007.00788.x     Document Type: Article

References (32)

1. Audrezet MP, Chen JM, Le Marechal C et al. Determination of the relative contribution of three genes - the cystic fibrosis transmembrane conductance regulator gene, the cationic trypsinogen gene, and the pancreatic secretory trypsin inhibitor gene-to the etiology of idiopathic chronic pancreatitis. Eur J Hum Genet 2005: 10: 100-106.
2. Mitchell RMS, Byrne MF, Baillie J. Pancreatitis. Lancet 2003: 361: 1447-1455.
3. Whitcomb DC, Gorry MC, Preston RA et al. Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet 1996: 14: 141-145.
4. Werlin SL, Kugathasan S, Frautschy BC. Pancreatitis in children. J Pediatr Gastroenterol Nutr 2003: 37: 591-595.
5. De Boeck K, Weren M, Proesmans M, Kerem E. Pancreatitis among patients with cystic fibrosis: Correlation with pancreatic status and genotype. Pediatrics 2005: 115: 463-469.
6. Grigorescu M, Grigorescu MD. Genetic factors in pancreatitis. Rom J Gastroenterol 2005: 14: 53-61.
7. Pfutzer RH, Barmada MM, Brunskill AP et al. SPINK1/PST1 polymorphisms act as disease modifiers in familial and idiopathic chronic pancreatitis. Gastroenterology 2000: 119: 615-623.
8. Cohn JA. Reduced CFTR function and the pathobiology of idiopathic pancreatitis. J Clin Gastroenterol 2005: 39: S70-S77.
9. Whitcomb DC, Ermentrout GB. A mathematical model of the pancreatic duct cell generating high bicarbonate concentrations in pancreatic juice. Pancreas 2004: 29: 30-40.
10. Rosenberg MF, Kamis AB, Alexandrov LA, Ford RC, Riordan JR. Purification and crystallization of the cystic fibrosis transmembrane conductance regulator (CFTR). J Biol Chem 2004: 279: 39051-39057.
11. Morinville V, Slivka A. Cystic fibrosis transmembrane regulator mutations and pancreatic disease: Closing the gap between genotype and phenotype. Gastrointest Endosc 2006: 63: 240-242.
12. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000: 67: 117-133.
13. Noone PG, Knowles MR. "CFTR-opathies": Disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations. Respir Res 2001: 2: 328-332.
14. Kanavakis E, Tzetis M, Antoniadi Th, Pistofidis G, Milligos S, Kattamis C. Cystic fibrosis mutation screening in CBAVD patients and men with obstructive azoospermia or severe oligospermia. Mol Hum Reprod 1998: 4: 333-337.
15. Tzetis M, Efthymiadou A, Strofalis S et al. CFTR gene mutations - including three novel nucleotide substitutions - and haplotype background in patients with asthma, disseminated bronchiectasis and chronic obstructive pulmonary disease. Hum Genet 2001: 108: 216-211.
16. Casals T, Aparisi L, Martinez-Costa C et al. Different CFTR mutational spectrum in alcoholic and idiopathic chronic pancreatitis? Pancreas 2004: 28: 374-379.
17. Ahmed N, Corey M, Forstner G et al. Molecular consequences of cystic fibrosis transmembrane regulator (CFTR) gene mutations in the exocrine pancreas. Gut 2003: 8: 1159-1164.
18. Cuppens H, Lin W, Jaspers M et al. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. J Clin Invest 1998: 101: 487-496.
19. Groman JD, Hefferon TW, Casals T et al. Variation in a repeat sequence determines whether a common variant of the cystic fibrosis transmembrane conductance regulator gene is pathogenic or benign. Am J Hum Genet 2004: 74: 176-179.
20. Azlami WM, Fogel EL, Schmidt S et al. ERCP findings in idiopathic pancreatitis: Patients who are cystic fibrosis gene positive and negative. Gastrointest Endosc 2006: 63: 234-239.
21. Chen JM, Mercier B, Audrezet MP, Ferec C. Mutational analysis of the human pancreatic secretory trypsin inhibitor (PST1) gene in hereditary and sporadic chronic pancreatitis. J Med Genet 2000: 37: 67-69.
22. Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000: 25: 213-216.
23. NCCLS. Sweat testing: Sample collection and quantitative analysis; approved guideline, 2nd edn. Wayne, PA: NCCLS, 2000 [NCCLS document C34-A2 (ISBN 1-56238-407-4)].
24. Kanavakis E, Efthymiadou A, Strofalis S, Doudounakis S, Traeger-Synodinos J, Tzetis M. Cystic fibrosis in Greece: Molecular diagnosis, haplotypes, prenatal diagnosis and carrier identification amongst high-risk individuals. Clin Genet 2003: 63: 400-409.
25. Ferec C, Raguenes O, Salomon R et al. Mutations in the cationic trypsinogen gene and evidence for genetic heterogeneity in hereditary pancreatitis. J Med Genet 1999: 36: 228-232.
26. Friedman KJ, Heim R, Knowles MR, Silverman LM. Rapid characterization of the variable length polythymidine tract in the cystic fibrosis (CFTR) gene: Association of the 5T allele with selected CFTR mutations and its incidence in atypical sinopulmonary disease. Hum Mutat 1997: 10: 108-115.
27. Rohlfs EM, Zhou Z, Sugarman EA et al. The I148T CFTR allele occurs on multiple haplotypes: A complex allele is associated with cystic fibrosis. Genet Med 2002: 4: 319-323.
28. Lamprecht G, Mau UA, Kortum C et al. Relapsing pancreatitis due to a novel compound heterozygosity in the CFTR gene involving the second most common mutation in Central Eastern Europe [CFTRdele2, 3(21kb)]. Pancreatology 2003: 269: 1-5.
29. Kaneko K, Nagasaki Y, Furukawa T et al. Analysis of the human pancreatic secretory trypsin inhibitor (PST1) gene mutations in Japanese patients with chronic pancreatitis. J Hum Genet 2001: 46: 293-297.
30. Bernardino ALF, Guarita DR, Mott CB et al. CFTR, PRSS1 and SPINK1 mutations in the development of pancreatitis in Brazilian patients. JOP 2003: 4: 169-177.
31. Chen JM, Ferec C, Cooper DN. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: General principles and overview. Hum Genet 2006: 120: 1-21.
32. Teich N, Ockenga J, Keim V, Mossner J. Genetic risk factors in chronic pancreatitis. J Gastroenterol 2002: 37: 1-9.